Dan Peer
Impact in
- Biomaterials top 0.01%
- Nanoparticle-Based Drug Delivery
- Drug Discovery top 0.2%
Papers in
- Biomaterials 53
- Nanoparticle-Based Drug Delivery 53
-
- RNA Interference and Gene Delivery 92
- Co-authors
- Jeffrey M. Karp (5 shared papers)Rimona Margalit (10 shared papers)Róbert Langer (4 shared papers)Seungpyo Hong (3 shared papers)Omid Cameron Farokhzad (3 shared papers)Daniel Rosenblum (15 shared papers)Wei Tao (2 shared papers)Nitin Joshi (1 shared paper)
- Journals
- Journal of Controlled Release (19 papers)ACS Nano (13 papers)Cancer Letters (10 papers)Advanced Drug Delivery Reviews (8 papers)Nature Nanotechnology (6 papers)
- Partner nations
- IsraelUnited StatesDenmark
In The Last Decade
Dan Peer
186 papers receiving 21.2k citations
Dan Peer's Hit Papers
Peers
Comparison fields: 5 of 155
- Biomaterials 9.1k
- Drug Discovery 74
- Pharmaceutical Science 1.1k
- Molecular Biology 6.6k
- Molecular Medicine 580
Countries citing papers authored by Dan Peer
This map shows the geographic impact of Dan Peer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Peer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Peer more than expected).
Fields of papers citing papers by Dan Peer
This network shows the impact of papers produced by Dan Peer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Peer. The network helps show where Dan Peer may publish in the future.
Co-authors
The 25 scholars most cited alongside Dan Peer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 191 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Nanocarriers as an emerging platform for cancer therapy Hit paper breakdown → | 2007 | 7700 |
| 2 | Progress and challenges towards targeted delivery of cancer therapeutics Hit paper breakdown → | 2018 | 1854 |
| 3 | CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy Hit paper breakdown → | 2020 | 495 |
| 4 | 2010 | 470 | |
| 5 | 2008 | 443 | |
| 6 | 2012 | 427 | |
| 7 | 2011 | 371 | |
| 8 | Cytosolic delivery of nucleic acids: The case of ionizable lipid nanoparticles Hit paper breakdown → | 2021 | 308 |
| 9 | Targeting cancer with mRNA–lipid nanoparticles: key considerations and future prospects Hit paper breakdown → | 2023 | 296 |
| 10 | 2018 | 285 | |
| 11 | 2018 | 274 | |
| 12 | 2007 | 238 | |
| 13 | 2011 | 227 | |
| 14 | 2021 | 227 | |
| 15 | 2020 | 214 | |
| 16 | 2003 | 210 | |
| 17 | 2019 | 197 | |
| 18 | 2020 | 192 | |
| 19 | 2019 | 191 | |
| 20 | 2004 | 187 |
About Dan Peer
Dan Peer is a scholar working on Biomaterials, Molecular Biology, Oncology, Pharmaceutical Science and Immunology, having authored 191 papers that have together received 21.8k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (92 papers), Nanoparticle-Based Drug Delivery (53 papers), Drug Transport and Resistance Mechanisms (9 papers), Advanced Drug Delivery Systems (5 papers), Nanoplatforms for cancer theranostics (5 papers), Immunotherapy and Immune Responses (5 papers), Tissue Engineering and Regenerative Medicine (4 papers) and Nanotechnology research and applications (4 papers). The work is most often cited by research in Biomaterials (9.1k citations), Drug Discovery (74 citations), Pharmaceutical Science (1.1k citations), Molecular Biology (6.6k citations) and Molecular Medicine (580 citations). Dan Peer has collaborated with scholars based in Israel, United States and Denmark. Frequent co-authors include Jeffrey M. Karp, Rimona Margalit, Róbert Langer, Seungpyo Hong, Omid Cameron Farokhzad, Daniel Rosenblum, Wei Tao, Nitin Joshi, Srinivas Ramishetti and Meir Goldsmith. Their work appears in journals such as Journal of Controlled Release, ACS Nano, Cancer Letters, Advanced Drug Delivery Reviews and Nature Nanotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.